Ever since the approval of the Covid-19 vaccine, there has been a significant increase in interest in nucleic acid-based medications and lipid nanoparticles (LNPs) for targeted drug delivery. With the rapid development of such systems, the development of quality characterization methods is trying to catch up and provide accurate robust analysis techniques. Meanwhile, more traditional techniques have been deployed…
Read the full Technical Bulletin here.